DoJ reclassifies medical marijuana as a less-dangerous drug, AP reports

The reclassification of medical marijuana by the Department of Justice signifies a potentially pivotal shift in regulatory stance, impacting the cannabis sector's legal status and associated businesses. This could lead to increased investment opportunities and a re-evaluation of risk by investors, particularly in US equities linked to the cannabis industry. Traders should consider both the immediate market implications and the longer-term changes in policy that could follow.